prof. MUDr. Michael Doubek, Ph.D.
Head of the research group, Michael Doubek Research Group: Genetic predisposition to hematologic disorders Neuroscience
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2144, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 866
2023
-
Single-cell RNA-sequencing enables tracking and characterization of rare CLL cells with the potential to cause refractoriness.
Year: 2023, type: Conference abstract
-
Subclonal architecture of chromosomes revealed by single-cell analysis of gene expression in a patient with clonal evolution of relapsing/refractory CLL.
Year: 2023, type: Conference abstract
-
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL
American Journal of Hematology, year: 2023, volume: 98, edition: 12, DOI
-
The final analysis of the international multicenter study conducted by ERIC, in Harmony.
Year: 2023, type: Conference abstract
-
The interplay between BcR signaling and the p53 pathway upon DNA damage in primary CLL cells.
Year: 2023, type: Conference abstract
-
The role of clonal hematopoiesis in the development of myeloid neoplasms post cytotoxic therapy - prospective study.
Year: 2023, type: Conference abstract
-
The role of clonal hematopoiesis variants in the development of myeloid neoplasms post cytotoxic therapy - case series.
Year: 2023, type: Conference abstract
-
Therapy of adult patients with acute lymphoblastic leukemia based on pediatricinspired protocols in the Czech republic in 2007-2020
Year: 2023, type: Conference abstract
-
Tracking CLL cells with aberrations in the TP53 gene using scRNA-seq in relapsed/refractory patients.
Year: 2023, type: Conference abstract
-
Transcription factor FoxO1 Mediates Adaptive Increase in Akt Activity and Cell Survival During BCR Inhibitor Therapy in CLL.
Year: 2023, type: Conference abstract